Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

August 5, 2024

View Complete Issue Table of Contents 2019

Download PDF: US English

Show Related
Terms Hide Related
Terms

Take CME
Exam

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-3 doi:10.58347/tml.2024.1708c

Disclosures

Objective(s)

Select a term to see related articles Bydureon BCise Byetta dulaglutide exenatide liraglutide Mounjaro Ozempic Rybelsus semaglutide tirzepatide Trulicity type 2 diabetes Victoza

View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes

Download PDF: US English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.